Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P06889 (
Mol
)
630,302
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The possibility that catecholamines modulate the
erythropoietin
-induced increase in production of cyclic AMP was investigated by examining the effect of
erythropoietin
and/or L-isoprenaline on the activity of the plasma membrane adenylate cyclase of anaemic rabbit bone marrow erythroblasts. Membranes isolated from cells cultured in the presence of both hormones exhibited both the transient stimulation of basal activity characteristic of
erythropoietin
action and the loss of the in vitro response to L-isoprenaline, concomitant with the loss of beta-adrenergic receptors, characteristic of L-isoprenaline stimulation. The presence of
erythropoietin
during cell culture with L-isoprenaline had no effect on the desensitization or number of beta-adrenergic receptors. The stimulation of adenylate cyclase by
erythropoietin
was observed also in the presence of the beta-antagonist propranolol, when both were added either to whole cells or to isolated membranes. We conclude that these two hormones activate adenylate cyclase independently of each other, via different receptors, with little evidence of cross-modulation.
Mol
Cell Endocrinol 1988 Apr
PMID:Independent activation of adenylate cyclase by erythropoietin and isoprenaline. 283 45
The gene for mouse
erythropoietin
was cloned and sequenced. We present here a preliminary analysis of the overall genomic organization of the coding portions and the two flanking regions of the gene. This is the third mammalian
erythropoietin
for which the sequence is available, but it represents the first from a nonprimate species. We investigated the evolutionary divergence of sequence and structure of the three erythropoietins and identified specific regions of the molecules that are apparently under various degrees, and perhaps different types, of functional constraint.
Mol
Cell Biol 1986 Mar
PMID:Cloning, sequencing, and evolutionary analysis of the mouse erythropoietin gene. 302 33
The 17-mer oligonucleotide probe homologous to the fragment of the gene for human erythrocyte differentiation factor
erythropoietin
was used to screen the human genomic library for this gene. Restriction analysis and partial sequencing of one of the identified clones have confirmed that the clone does contain the human
erythropoietin
gene. We are planning to use the cloned human
erythropoietin
gene for developing a stably transfected mammalian cell line that should secrete
erythropoietin
.
Mol
Gen Mikrobiol Virusol 1988 Jul
PMID:[Cloning of human erythropoietin gene]. 319 67
Injection of cobalt into rats resulted in
erythropoietin
(
EPO
) mRNA accumulation in the kidney. The same response was obtained upon bleeding. No
EPO
mRNA was detected in the spleen, salivary gland, or thymus following cobalt injection or bleeding. In some animals, but not in others,
EPO
mRNA was also expressed in the liver in response to cobalt injection. Time course studies showed that message appearance begins sometime between 3 and 6 h after cobalt injection. This correlated very well with the
EPO
concentration in the circulation;
EPO
levels in the circulation were the same as those of controls at 3 h but increased to six- to sevenfold that of controls by 6 h after cobalt injection. The mature
EPO
mRNA in the rat and mouse comigrated with the 18S rRNA, indicating that it is about 1,850 nucleotides in length.
Mol
Cell Biol 1986 Jul
PMID:Expression of the erythropoietin gene. 346 25
The erythroleukemia cell line IW32, derived by transformation with the Friend murine leukemia virus, has been shown previously to produce
erythropoietin
(
EPO
) constitutively. Here we demonstrate that, in addition to the normal mouse
EPO
locus, this cell line has another
EPO
locus which has undergone rearrangement and amplification. Both loci were cloned, and the rearrangement breakpoint of the second
EPO
locus was located within a 1.1-kilobase region upstream of an otherwise apparently normal
EPO
gene. There are no viral sequences present in the immediate vicinity of the rearranged
EPO
gene. DNase I digestion studies suggest that the rearranged gene is in a region where the chromatin is more sensitive to DNase hydrolysis than is the site of the normal gene. We conclude, tentatively, that the rearranged
EPO
locus is probably the transcriptionally active one and that either proviral sequences are acting at a distance to activate the
EPO
gene or the rearrangement itself has served to activate the gene.
Mol
Cell Biol 1987 Jan
PMID:Rearrangement and expression of erythropoietin genes in transformed mouse cells. 356 95
The gene for murine
erythropoietin
(
EPO
) was isolated from a mouse genomic library with a human
EPO
cDNA probe. Nucleotide sequence analysis permitted the identification of the murine
EPO
coding sequence and the prediction of the encoded amino acid sequence based on sequence conservation between the mouse and human
EPO
genes. Both the coding DNA and the amino acid sequences were 80% conserved between the two species. Transformation of COS-1 cells with a mammalian cell expression vector containing the murine
EPO
coding region resulted in secretion of murine
EPO
with biological activity on both murine and human erythroid progenitor cells. The transcription start site for the murine
EPO
gene in kidneys was determined. This permitted tentative identification of the transcription control region. The region included 140 base pairs upstream of the cap site which was over 90% conserved between the murine and human genes. Surprisingly, the first intron and much of the 5'- and 3'-untranslated sequences were also substantially conserved between the genes of the two species.
Mol
Cell Biol 1986 Mar
PMID:Murine erythropoietin gene: cloning, expression, and human gene homology. 377 94
Regulation of the production of
erythropoietin
occurs in the kidney and liver largely through control of accumulation of
erythropoietin
mRNA. Erythropoietin mRNA was first detected in kidneys at 1.5 h postanemia and reached a plateau value at least 200-fold above the control value by 4 to 8 h. A 20-base sequence immediately upstream from the reported
erythropoietin
mRNA initiation site is complementary to a hypervariable sequence in 18S rRNA.
Mol
Cell Biol 1986 Jul
PMID:Anemia induces accumulation of erythropoietin mRNA in the kidney and liver. 378 9
A murine retrovirus (MRSV) containing the src gene of Rous sarcoma virus has been shown to cause an erythroproliferative disease in mice (S. M. Anderson and E. M. Scolnick, J. Virol. 46:594-605, 1983). We now demonstrate that this same virus can transform erythroid progenitor cells in vitro. Infection of fetal liver cells or spleen and bone marrow cells from phenylhydrazine-treated adult mice gave rise to colonies of erythroid cells which grew in methylcellulose under conditions not favorable for the growth of normal erythroid cells. The presence of pp60src in the transformed erythroid cells was demonstrated by an immune complex protein kinase assay. The time course of appearance and subsequent differentiation of erythroid colonies indicated that the target cell for MRSV was a 6- to 8-day burst-forming unit. Differentiation of the erythroid progenitors was not blocked by the presence of pp60src, and the cells retained sensitivity to the hormone
erythropoietin
. In fact, the transformed cells exhibited increased hormone sensitivity since the number, the size, and the extent of hemoglobinization of the colonies were all increased by the addition of small amounts of
erythropoietin
. MRSV was not susceptible to restriction by the Fv-2 locus, as MRSV could transform hematopoietic cells from C57BL/6 mice. These results indicate that (i) the erythroid proliferation observed in vivo is caused by a direct effect of MRSV on erythroid progenitors and (ii) the transformed erythroid precursors acquire a growth advantage over uninfected cells without losing the ability to differentiate and respond to physiologic regulators.
Mol
Cell Biol 1985 Dec
PMID:A murine recombinant retrovirus containing the src oncogene transforms erythroid precursor cells in vitro. 393 14
Splenic erythroblasts of mice infected with the anemia-inducing strain of Friend virus can be isolated in large numbers with less than 5% contamination with other cell types. In short-term culture, the isolated cells will initiate globin synthesis and undergo other aspects of terminal differentiation only if
erythropoietin
(EP) is added to the medium. An early effect of the hormone on these cells is stimulation of total RNA synthesis. EP also causes initiation of transcription of the beta-globin genes after a lag period of 4 to 6 h. By 6 h, the transcription rate of beta-globin RNA is enhanced threefold, and by 12 h, it is nearly maximal at ca. 20 times the level of control cells which received no EP. Transcription rates of alpha and beta-globin genes are approximately equal to each other throughout the period of terminal differentiation. In the splenic erythroblasts, the chromatin structure in the vicinity of the beta-major globin gene was analyzed with two nucleases during these transcription rate changes. No S1 nuclease-hypersensitive site is detectable near the gene. The beta-major gene is quite sensitive to DNase I in comparison with the albumin gene; however, the level of sensitivity is the same before EP addition as it is during maximal gene transcription after EP addition. Also, a hypersensitive site near the 5' cap site of the beta-major gene is quantitatively equivalent both before and after EP addition. Analysis of cytosine methylation at two sites upstream from the gene showed no changes upon induction of beta-globin gene transcription by EP. Thus, the initiation of beta-globin transcription by EP appears to be at some step after chromatin structural alteration such as synthesis, release, or activation of a specific transcription initiation factor.
Mol
Cell Biol 1985 Apr
PMID:Control of globin gene transcription by erythropoietin in erythroblasts from friend virus-infected mice. 399 Jun 88
A Rauscher virus (RV)-transformed erythroid cell line, RA-1, was shown to be a non-producer cell line. RA-1 cells express not only gp51-54 env-related glycoprotein, but also gp70, which is more closely related to gp51-54 coded by a recombinant env gene than to the MuLV-R gp70. RA-1 cells could be infected by Friend, Moloney and Gross viruses, but not by the homologous Rauscher murine leukaemia virus. Rescue of spleen focus-forming activity was obtained on infection of these cells with MuLV-F or MuLV-
Mol
, but not with MuLV-Gross. The RNA of the RV complex resembles closely that of Friend virus (FV). It contains a 32S, presumably defective, genome, which most likely is responsible for spleen focus formation, and a 35S helper virus genome. Oligonucleotide fingerprint data suggest that RV has evolved independently of FV. Erythroid early BFU-E cells of mice infected with RV of Friend helper virus-infected RA-1 cells were shown to require no addition of conditioned medium to form large erythroid colonies (BFU-E) in the presence of only small amounts of
erythropoietin
.
...
PMID:Rauscher spleen focus-forming virus: biological properties and relationship to helper viruses. 629 33
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>